European Wrap – Will Covid Overshadow Earnings?
Youth-led solutions during COVID-19: Harnessing social media
The "Biblical" Default Wave Arrives: Here Is The Avalanche Of Bankruptcies Unleashed By Coronavirus
Etihad Airways to offer COVID-19 home testing service prior to travel
Global coronavirus cases rise above 13 million, WHO sounds alarm
Air pollution exposure linked to higher COVID-19 cases and deaths – new study
The Fed Is Trapped In QE As Interest Rates Can't Rise Ever Again
South Africa Reintroduces Ban On Alcohol Sales To Combat Virus Pandemic
A top analyst turns the spotlight on Moderna, fueling a fast-and-furious Street race over the future of mRNA
Facts or fake news: Revealing patterns in the COVID-19 tweets of Trudeau and Trump
Pfizer, BioNTech Score Fast Track Status For Covid-19 Vaccine Candidates
BBRG: Big Tech Drives the Stock Market Without Much U.S. Help
Airlines got travelers comfortable about flying again once before – but 9/11 and a virus are a lot different
Three million more guns: The Spring 2020 spike in firearm sales
South Korea: 1 in 3 Covid-19 Patients Improved With Gilead’s Remdesivir
Futures Jump Above 3,200 On Vaccine Optimism, Merger Monday
Your coping and resilience strategies might need to shift as the COVID-19 crisis continues
Young musicians can perform on virtual stages when schools are closed
Mask resistance during a pandemic isn't new – in 1918 many Americans were 'slackers'
What US medical supply chain can learn from the fashion industry
Homeless numbers set to rise – but lockdown shows government can solve this
Disney World Cautiously Reopens; Analyst Optimistic On Outlook
Two years after a ‘positive’ result tanked their stock, Ovid's Jeremy Levin wins a partner for the PhIII journey
The Fed Is Trapped In QE As Interest Rates Can’t Rise Ever Again.
Tesla Sets Date For “Battery Day”, Analyst Says It Could Be 'Game-Changing'
Amgen Pours A Further $421M Into China’s BeiGene
Macro Briefing | 13 July 2020
GM Cutting Third Shift At Missouri Plant After Workers Fail To Show Up Due To COVID Fears
BeiGene Plans $2B Direct Offering; Analyst Sees Further Upside Ahead
ElectroCore Pops 160% On FDA Nod For Covid-19 Asthma Device